Lamotrix

Lamotrigine, the active ingredient in Lamotrix, is an anticonvulsant presented as an oral tablet for oral use. It is employed to treat epilepsy and to stabilize mood in bipolar disorder, helping patients achieve seizure control and mood regulation. It works by modulating neuronal excitability, offering a therapeutic option for patients who require long‑term seizure management.

GNH USA supplies Lamotrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal voltage‑gated sodium channels.

Epilepsy: reduces frequency and severity of focal and generalized seizures. Bipolar disorder: maintains mood stability and decreases recurrence of depressive and manic episodes. Partial seizures: provides effective control of focal onset seizures when used as adjunct therapy.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., maculopapular rash) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Lamotrigine requires careful monitoring and patient education to minimize risks. - Start low and titrate slowly: reduces risk of skin rash. - Avoid use in patients with known hypersensitivity to lamotrigine: may cause severe reactions. - Use caution in hepatic impairment: metabolism may be altered. - Do not discontinue abruptly: sudden cessation can increase seizure frequency. - Store at room temperature: keep in original packaging, protect from moisture.

Lamotrigine interacts with several medications that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: increases lamotrigine levels, raising toxicity risk. - Carbamazepine: decreases lamotrigine levels, potentially reducing efficacy. - Phenobarbital: lowers lamotrigine concentrations, may require dose adjustment. - Phenytoin: reduces lamotrigine exposure, may compromise seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may increase lamotrigine clearance, necessitating dose review. - Serotonergic agents: monitor for additive risk of serotonin syndrome. - Other antiepileptic drugs: may require individualized dosing and therapeutic monitoring.